Citation Impact
Citing Papers
The cardiac response to exercise in cirrhosis
2001
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Pain Intensity on the First Day after Surgery
2013 Standout
Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up
2004
Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct‐ligated rats
2005
Hepatocellular carcinoma
2003 Standout
Abdominal MR: liver and pancreas
1999
In vitro biocompatibility performance of Physioneal
2003
Chipping into the human genome: novel insights for transplantation
2006
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation
1999
Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids
2015
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA: RESULTS IN 207 PATIENTS1
2000
Contrast agents in magnetic resonance imaging of the liver: Present and future
1998
The utility of marginal donors in liver transplantation
2003
Hepatic MRI with SPIO: detection and characterization of focal liver lesions
1998
Hepatocellular carcinoma
2012 Standout
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
2004
The use of antibodies against the IL-2 receptor in transplantation
1998
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
Ischemia/Reperfusion Injury
2002
Central nervous system complications in liver transplant recipients – incidence, timing, and long‐term follow‐up
2000
Vascular disorders of the liver # †
2008 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
High incidence of recurrence and hematologic events following liver transplantation for Budd–Chiari syndrome
2005
Management of Hepatocellular Carcinoma *
2005 Standout
Cytotoxicity of Nanoparticles
2007 Standout
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
2006
Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management
2015 Standout
Treatment of Budd‐Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto‐systemic shunt and liver transplantation
2004
Outcome after liver re-transplantation in patients with recurrent chronic hepatitis C
2007
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Extended Resections for Hilar Cholangiocarcinoma
1999
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
2004 Standout
Vascular Invasion and Histopathologic Grading Determine Outcome After Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis
2001
NC100150 injection, a preparation of optimized iron oxide nanoparticles for positive-contrast MR angiography
2000
Hepatocellular Carcinoma in the Cirrhotic Liver: Double-Contrast MR Imaging for Diagnosis
2000
Glomerular Endothelium Exhibits Enhanced Expression of Costimulatory Adhesion Molecules, CD80 and CD86, by Warm Ischemia/Reperfusion Injury in Rats
2002 StandoutNobel
Liver Transplantation for Hereditary Hemorrhagic Telangiectasia
2006
Contrast Agents for MR Imaging of the Liver
2001
Postoperative pancreatic fistula: An international study group (ISGPF) definition
2005 Standout
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Liver Disease in Patients with Hereditary Hemorrhagic Telangiectasia
2000
Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up
2004
Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders1
2002
Hepatic involvement in hereditary hemorrhagic telangiectasia: An unusual indication for liver transplantation
2001
Tomographic imaging using the nonlinear response of magnetic particles
2005 StandoutNature
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
2012 Standout
Laparoscopic versus open surgery for suspected appendicitis
2002
Cholangiocarcinoma
2005
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
Cholangiocarcinoma
2007 Standout
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
The place of liver transplantation in Caroli's disease and syndrome
2006
Infection in Solid-Organ Transplant Recipients
2007 Standout
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients
2011
Model for end-stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia
2006
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Liver involvement in hereditary hemorrhagic telangiectasia (HHT)
2007
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results
2003
Modification of cardiac function in cirrhotic patients with and without ascites
2000
Nano-magnetite (Fe3O4) as a support for recyclable catalysts in the development of sustainable methodologies
2013 Standout
Budd-Chiari Syndrome: Current Management Options
2001
Laparoscopic versus open surgery for suspected appendicitis
2004
The role of immunosuppression in recurrence of hepatitis C
2003
Sympathetic Neural Mechanisms of Cyclosporine-Induced Hypertension*
1996
Prospective, Randomized Trial of Octreotide to Prevent Pancreatic Fistula After Pancreaticoduodenectomy for Malignant Disease
1997
Robbins and Cotran Pathologic Basis of Disease
2020 Standout
Superparamagnetic Iron Oxide Nanoparticles in Biomedicine: Applications and Developments in Diagnostics and Therapy
2013
Infections in solid-organ transplant recipients
1997
Laparoscopic versus open surgery for suspected appendicitis
2018 Standout
Laparoscopic versus open surgery for suspected appendicitis
2010
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
2011
Green synthesis of metal nanoparticles using plants
2011 Standout
Nanotechnology and Mri Contrast Enhancement
2010
Pancreaticojejunostomy versus pancreaticogastrostomy in reconstruction following pancreaticoduodenectomy
2000
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Graphene-Like Two-Dimensional Materials
2013 Standout
Magnetic Iron Oxide Particles Coated with Carboxydextran for Parenteral Administration and Liver Contrasting
1997
Glucose Degradation Products: Relationship with Cell Damage
2000
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Aspergillus fumigatusand Aspergillosis
1999 Standout
Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal
1995
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
2000 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Hydroxymethylfurfural, A Versatile Platform Chemical Made from Renewable Resources
2013 Standout
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
2018
Works of H. Keck being referenced
Treatment of the Budd‐Chiari syndrome with orthotopic liver transplantation and long‐term anticoagulation
1994
Biocompatibility and buffers: Effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function
1998
Technique and Results of Biliary Reconstruction Using Side-to-Side Choledochocholedochostomy in 300 Orthotopic Liver Transplants
1994
Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization.
1998
Pilot study: Carolina rinse solution improves graft function after orthotopic liver transplantation in humans
1997
Fungal infections in liver transplant recipients
1994
Mycophenolate mofetil in combination with tacrolimus versus neoral after liver transplantation
1999
A PROSPECTIVE RANDOMIZED TRIAL COMPARING INTERLEUKIN-2 RECEPTOR ANTIBODY VERSUS ANTITHYMOCYTE GLOBULIN AS PART OF A QUADRUPLE IMMUNOSUPPRESSIVE INDUCTION THERAPY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION
1997
Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
1996
Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma First long-terms results
1998
Effective therapy for hepatic M. Osler with systemic hypercirculation by ligation of the hepatic artery and subsequent liver transplantation
1998
Mycobacterial infection after liver transplantation
1995
COMPARISON OF FK506- AND CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN PRIMARY ORTHOTOPIC LIVER TRANSPLANTATION
1995
Changes at the extracellular matrix during acute and chronic rejection in human liver transplantation
1998
Protection of pancreatic and biliary anastomosis after partial duodenopancreatectomy by external drainage.
1992
Die laparoskopische Appendektomie im Vergleich zur konventionellen Operationstechnik bei akuter Appendizitis
1995
The peritoneal fibroblast and the control of peritoneal inflammation.
1996
[Cause of death after liver transplantation: an analysis of 41 cases in 382 patients].
1995
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis.
1995
Liver transplantation in HBsAg positive patients.
1990
Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy.
1993
[Therapy of unilobar Caroli syndrome by liver resection].
1994
Liver transplantation for Budd-Chiari syndrome.
1994
[Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
1995
Changes at the extracellular matrix during acute and chronic rejection in human liver transplantation
1998
Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma First long-terms results
1998